N.H. Gower - Concepedia

Concepedia

Author

N.H. Gower

University College London

Also Known As

N GOWER, N Gower, N H Gower, N. Gower, N. H. Gower, N.H Gower, N.H. Gower, NH Gower

23

Publications

1.6K

Citations

13

H-Index

17

Concepts

All Affiliations

University College London St Bartholomew's Hospital Medical Research Council London Cancer Royal Marsden Hospital

NG

About

N.H. Gower is an author at University College London specializing in radiation oncology, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	171
2	Health Sciences	4	4	148
3	Pathology	2	2	70
4	Nursing	1	1	27
5	Immunology	1	1	35

N.H. Gower

×

13

Publications

1.6K

Citations

13

H-Index

	Year	Citations
Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life M.H. Cullen, Lucinda Billingham, C.M. Woodroffe, Journal of Clinical Oncology	1999	448
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1 David Waller, Michael Peake, Richard Stephens, European Journal of Cardio-Thoracic Surgery	2004	388
Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy R L Souhami, SG Spiro, R.M. Rudd, JNCI Journal of the National Cancer Institute	1997	203
Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Phase III Randomized Study of the London Lung Cancer Group R.M. Rudd, N.H. Gower, Stephen Spiro, Journal of Clinical Oncology	2004	157
Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer Julia Brown, H. Thorpe, Vicky Napp, Journal of Clinical Oncology	2005	83
Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial. R L Souhami, R.M. Rudd, M C Ruiz de Elvira, Journal of Clinical Oncology	1994	67
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer Siow Ming Lee, L. E. James, W. Qian, Thorax	2008	65
The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting RJ Stephens, Julia Brown, DJ Fairlamb, UCL Discovery (University College London) MedicineCancer ManagementClinical TrialsBig Lung TrialPreliminary Results	2002	50
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma Dean A. Fennell, Jeremy Steele, Jonathan Shamash, Lung Cancer First-line TherapyMalignant Pleural MesotheliomaPhase Ii TrialPleural DiseaseCancer Treatment	2004	47
A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma C Mulatero, Richard T. Penson, D. Papamichael, Lung Cancer Malignant Pleural MesotheliomaImmunologyPathologyPhase Ii StudyPleural Disease	2001	35

Page 1